Physician profile
Jesse Loeffler
NPI 1972866515
$812.93
in general payments reported to CMS, 2019-2025
12 companies · $28.13 in 2025
The $28.13 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $48.92 · 2021: $217 · 2022: $94.17 · 2023: $209 · 2024: $24.29 · 2025: $28.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.45 | 2019-2022 | |
| Myriad Women'S Health, INC. | $164.18 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.34 | 2019-2022 | |
| Organon LLC | $35.49 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $33.62 | 2021-2022 | |
| Biogen, INC. | $28.13 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $24.29 | 2024 | Thinprep 2000 Processor |
| Astellas Pharma US INC | $21.32 | 2023 | Veozah |
| Medtronic, INC. | $18.82 | 2021 | |
| Hologic INC | $14.63 | 2021 | |
| Allergan, INC. | $13.07 | 2019 | |
| Daiichi Sankyo INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Loeffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.